pentobarbital has been researched along with ANS (Autonomic Nervous System) Diseases in 1 studies
Pentobarbital: A short-acting barbiturate that is effective as a sedative and hypnotic (but not as an anti-anxiety) agent and is usually given orally. It is prescribed more frequently for sleep induction than for sedation but, like similar agents, may lose its effectiveness by the second week of continued administration. (From AMA Drug Evaluations Annual, 1994, p236)
pentobarbital : A member of the class of barbiturates, the structure of which is that of barbituric acid substituted at C-5 by ethyl and sec-pentyl groups.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Pentobarbital was then administered, resulting in excellent control of behavioral, autonomic, and psychiatric symptoms and in rapid reduction or avoidance of benzodiazepines." | 1.31 | Pentobarbital for severe gamma-butyrolactone withdrawal. ( Aaron, CK; Burns, MJ; Greenberg, MJ; Sivilotti, ML, 2001) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sivilotti, ML | 1 |
| Burns, MJ | 1 |
| Aaron, CK | 1 |
| Greenberg, MJ | 1 |
1 other study available for pentobarbital and ANS (Autonomic Nervous System) Diseases
| Article | Year |
|---|---|
Pentobarbital for severe gamma-butyrolactone withdrawal.
Topics: 4-Butyrolactone; Adult; Arousal; Autonomic Nervous System Diseases; Emergency Service, Hospital; Fem | 2001 |